Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
© 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference | Sex/Agea | Outcome | Complication | Original diagnosis | Adjunct study | Cartilage | Necrosis | Round cell | Mitosis |
---|---|---|---|---|---|---|---|---|---|
Jones [9] | F/28 wk | Died at 1 hr | RD | Hamartoma | - | + | NS | NS | NS |
Robb [3] | M/NS | Well at 10 mo | None | Fibrosarcoma | - | NS | NS | + | Not numerous |
Guccion and Rosen [5] | M/NS | Died shortly after birth | NS | Leiomyosarcoma | - | NS | NS | NS | 15/10 hpf |
Haller et al. [8] | F/40 wk | Died at 8 hr | H, RD | Mesenchymal tumor | - | NS | NS | + | None |
Warren et al. [7] | F/30-33 wk | Intraoperative death | PHA, RD | Mesenchymal malformation | EM | Entrappedb | NS | NS | 1-5/hpf |
Jimenez et al. [4] | M/36 wk | Well at 34 mo | H, PHA, RD | Leiomyosarcoma | EM | NS | NS | NS | Occasional |
Pettinato et al. [2] | M/NS | Well at 6 yr | PE, RD | Fibrosarcoma | IHC, EM | Entrapped | + | + | 8-12/10 hpf |
M/NS | Well at 3 mo | PE, RD | |||||||
Khong and Keeling [6] | M/27 wk | Termination | H, PHA | Mesenchymal | - | + | NS | NS | Frequent |
McGinnis et al. [1] | M/33 wk | Intraoperative death | H, PHA, RD | CPMT | IHC, EM, flow cytometry | + | - | NS | 1/10 hpf |
Alobeid et al. [17] | F/35 wk | Well at 12 mo | RD | CPMT | IHC, EM, karyotyping | Entrapped | + | NS | 0-3/10 hpf |
Kuhnen et al. [10] | NS/NS | Well at 8 mo | None | Fibrosarcoma | IHC | + | - | NS | 1/10 hpf |
Reiss et al. [13] | M/24 wk | Termination | NS | CPMT | IHC | - | + | NS | 0-4/10 hpf |
Horikoshi et al. [12] | M/30 wk | Intrauterine death | H, PE | CPMT | IHC | - | + | NS | NS |
Dishop [14] | M/28 wk | Died 24 hr | H, RD | CPMT | IHC | + | - | NS | Occasional |
de Noronha et al. [15] | M/24 wk | Intrauterine death | H, PHA | CPMT | IHC, EM | + | NS | NS | Frequent |
Huppmann et al. [16] | M/23 wk, 6 wk postnatal | Well at 6.5 yr | H, RD | CPMT | IHC, karyotyping | + | - | NS | Brisk/occasional |
Current case | F/1 mo | Well at 2 yr | None | CPMT | IHC, EM | + | + | + | 8/10 hpf |
CPMT, congenital peribronchial myofibroblastic tumor; F, female; RD, respiratory distress; NS, not specified; M, male; hpf, high power fields; H, hydrops; PHA, polyhydramnios; EM, electron microscopy; PE, pleural effusion; IHC, immunohistochemistry.
aGestational age for all cases except the current case;
bRecognized as non-neoplastic.
Reference | Sex/Age |
Outcome | Complication | Original diagnosis | Adjunct study | Cartilage | Necrosis | Round cell | Mitosis |
---|---|---|---|---|---|---|---|---|---|
Jones [9] | F/28 wk | Died at 1 hr | RD | Hamartoma | - | + | NS | NS | NS |
Robb [3] | M/NS | Well at 10 mo | None | Fibrosarcoma | - | NS | NS | + | Not numerous |
Guccion and Rosen [5] | M/NS | Died shortly after birth | NS | Leiomyosarcoma | - | NS | NS | NS | 15/10 hpf |
Haller et al. [8] | F/40 wk | Died at 8 hr | H, RD | Mesenchymal tumor | - | NS | NS | + | None |
Warren et al. [7] | F/30-33 wk | Intraoperative death | PHA, RD | Mesenchymal malformation | EM | Entrapped |
NS | NS | 1-5/hpf |
Jimenez et al. [4] | M/36 wk | Well at 34 mo | H, PHA, RD | Leiomyosarcoma | EM | NS | NS | NS | Occasional |
Pettinato et al. [2] | M/NS | Well at 6 yr | PE, RD | Fibrosarcoma | IHC, EM | Entrapped | + | + | 8-12/10 hpf |
M/NS | Well at 3 mo | PE, RD | |||||||
Khong and Keeling [6] | M/27 wk | Termination | H, PHA | Mesenchymal | - | + | NS | NS | Frequent |
McGinnis et al. [1] | M/33 wk | Intraoperative death | H, PHA, RD | CPMT | IHC, EM, flow cytometry | + | - | NS | 1/10 hpf |
Alobeid et al. [17] | F/35 wk | Well at 12 mo | RD | CPMT | IHC, EM, karyotyping | Entrapped | + | NS | 0-3/10 hpf |
Kuhnen et al. [10] | NS/NS | Well at 8 mo | None | Fibrosarcoma | IHC | + | - | NS | 1/10 hpf |
Reiss et al. [13] | M/24 wk | Termination | NS | CPMT | IHC | - | + | NS | 0-4/10 hpf |
Horikoshi et al. [12] | M/30 wk | Intrauterine death | H, PE | CPMT | IHC | - | + | NS | NS |
Dishop [14] | M/28 wk | Died 24 hr | H, RD | CPMT | IHC | + | - | NS | Occasional |
de Noronha et al. [15] | M/24 wk | Intrauterine death | H, PHA | CPMT | IHC, EM | + | NS | NS | Frequent |
Huppmann et al. [16] | M/23 wk, 6 wk postnatal | Well at 6.5 yr | H, RD | CPMT | IHC, karyotyping | + | - | NS | Brisk/occasional |
Current case | F/1 mo | Well at 2 yr | None | CPMT | IHC, EM | + | + | + | 8/10 hpf |
CPMT, congenital peribronchial myofibroblastic tumor; F, female; RD, respiratory distress; NS, not specified; M, male; hpf, high power fields; H, hydrops; PHA, polyhydramnios; EM, electron microscopy; PE, pleural effusion; IHC, immunohistochemistry. Gestational age for all cases except the current case; Recognized as non-neoplastic.